Nivolumab-induced acute demyelinating polyradiculoneuropathy mimicking Guillain-Barré syndrome
- 18 April 2018
- journal article
- letter
- Published by Elsevier BV in Journal of the Neurological Sciences
- Vol. 390, 115-116
- https://doi.org/10.1016/j.jns.2018.04.028
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- PD-1 Antibody-induced Guillain-Barré Syndrome in a Patient with Metastatic MelanomaActa Dermato-Venereologica, 2017
- Neurologic complications of immune checkpoint inhibitorsCurrent Opinion in Neurology, 2016
- Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain–Barré syndrome: a case reportJapanese Journal of Clinical Oncology, 2016
- A case of fatal Guillain–Barre syndrome from anti-PD1 monoclonal antibody useZeitschrift für Krebsforschung und Klinische Onkologie, 2016
- The future of immune checkpoint therapyScience, 2015
- Corticosteroids for Guillain-Barré syndromePublished by Wiley ,2006
- Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain–Barré syndromeJournal of Clinical Neuroscience, 2005